Author

Fraser Inglis

Observed institutions: Brighton and Sussex Medical School, Stavanger University Hospital, Akershus University Hospital, Golden Jubilee National Hospital, Karolinska Institutet, University College London, University of Brescia, Newcastle University

OpenAlex ID: A5104547133

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

2021 · Daniel K Burns, Robert C Alexander, et al. · The Lancet Neurology · 139

Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment

2018 · David A. Wolk, Carl Sadowsky, et al. · JAMA Neurology · 89

Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI)

2007 · Geoffrey C. Dunbar, Fraser Inglis, et al. · Journal of Psychopharmacology · 75

Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: Randomised study

2014 · Zuzana Walker, Emilio Moreno, et al. · The British Journal of Psychiatry · 60

Safety and tolerability of once‐daily versus twice‐daily memantine: a randomised, double‐blind study in moderate to severe Alzheimer's disease

2007 · Roy W. Jones, Antony Bayer, et al. · International Journal of Geriatric Psychiatry · 44

Evolution of clinical features in possible DLB depending on FP-CIT SPECT result

2016 · Zuzana Walker, Emilio Moreno, et al. · Neurology · 18

[o1–12–01]: [18f]flutemetamol Amyloid Scanning in a Phase Iii Amnestic Mild Cognitive Impairment Study: Additional Influence of Other Biomarkers in Estimating Risk of Conversion to Probable Alzheimers Disease

2017 · Chris J. Buckley, Fraser Inglis, et al. · Alzheimer s & Dementia · 1

O1‐04‐05: Results of a double‐blind phase 2b study of monthly mimopezil implants compared to oral donepezil in patients with moderate Alzheimer's disease (BRAINZ study)

2009 · David Wilkinson, Sharon Cohen, et al. · Alzheimer s & Dementia · 1

Issues in the management of Alzheimer's disease

2002 · Martin Farlow, Fraser Inglis · Primary Care and Community Psychiatry · 1

APOE4 carrier identification, genetic disclosure and amyloid status: Results from the generation 2 program Alzheimer's disease prevention clinical trial at Glasgow Memory Clinic

2020 · Jennifer Lynch, Kirsty Hendry, et al. · Alzheimer s & Dementia

P1‐264: Generation Program Recruitment Strategy (alzheimer Disease Prevention Clinical Trials) Carried Out by Glasgow Memory Clinic

2019 · Kirsty Hendry, Jennifer Lynch, et al. · Alzheimer s & Dementia

P4‐272: the Research Lumbar Puncture: Further Evidence of Safety and Tolerability When Undertaken by Experienced Anaesthetists

2014 · Fraser Inglis, Malcolm Sim, et al. · Alzheimer s & Dementia

O4‐06‐03: Prevalence of Dlb Features in Possible Dementia With Lewy Bodies and Its Relationship to Changes in Dementia Diagnostic Category After Dopamine Transporter Imaging Using Datscan™

2014 · Zuzana Walker, Michael Rainer, et al. · Alzheimer s & Dementia

P2–097: Changes in dementia diagnostic category and diagnostic confidence following dopamine transporter SPECT imaging (DaTscanTM ‐ Ioflupane 123I) in people with an uncertain diagnosis of dementia with Lewy bodies (possible DLB)

2013 · Zuzana Walker, Alan Thomas, et al. · Alzheimer s & Dementia

P1-429 Four-weekly dose escalation provides improved gastrointestinal tolerability with rivastigmine treatment

2004 · Fraser Inglis · Neurobiology of Aging

Works count: 15

Citation count: 428

H-index: 6

I10-index: 6